Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutchs pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nations first cancer prevention research program, as well as the clinical coordinating center of the Womens Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.
This research opportunity is with the McElrath laboratory and the HIV Vaccine Trials Network (HVTN). Our lab is recruiting an entry-level or experienced research technician to perform complex research assays to characterize primarily T-cell responses utilizing flow cytometry induced by investigational vaccines or during infection with SARS-CoV-2, HIV and other pathogens, such as malaria and TB. They will be responsible for standardizing and performing novel assays, and collecting and analyzing the data. They will interpret and report on experimental results and assist with data presentation. They will assist in writing laboratory SOPs, reports, and other documentation. The technician will report to a manager and work closely with a technical team.
The HVTNs mission is to facilitate the process of testing preventive vaccines against HIV/AIDS or other infectious diseases. The organization conducts all phases of clinical trials from evaluating experimental vaccines for safety and the ability to stimulate immune responses through to testing vaccine efficacy. The HVTN laboratory is responsible for conducting laboratory-based studies to evaluate the immunogenicity of investigational vaccines.
Maintain a high level of accuracy for all work
Work well as team-member, participate in positive communication, and foster an environment that allows all laboratory staff to work well together
Independently perform immunological, flow cytometry and other experimental assays
Troubleshoot and optimize experimental methods, results and analysis
Lead, train or coordinate other technicians, or team members on laboratory techniques and assays
Review the literature to learn and trouble-shoot new methods and stay informed on the HIV/SARS-CoV-2 vaccines and immunology
Prepare and present written or oral progress reports concerning studies including assembly, organization, and interpretation of data
Maintain accurate documentation for experiments and quality control for the laboratory
Supervise and carry out maintenance, and troubleshooting and QC of laboratory equipment
May perform data analysis, interpretation, and statistical analyses
Other duties as assigned
Senior level position requires a BA/BS and 4+ years relevant experience working in a laboratory, or a Masters degree and an equivalent experience. Requires independent research experience with immunological assays and training and supervision of other staff
Experience with immunology, flow cytometry, COVID, HIV/AIDS and/or cellular assays are strongly desired
Motivation, adaptability and ability to be a strong team player are essential, as is a keen interest in the SARS-CoV-2/COVID-19 & HIV vaccine field
The candidate must be someone with great attention to details, well-organized, self-motivated, and able to efficiently manage time and experiments. Experience in a GLP or GCLP setting or clinical experience, with strong documentation skills is also desirable
Applicants must be willing to work with biohazardous/infectious agents (e.g., bloodborne pathogens, including SARS-CoV-2 & HIV-1) and also be flexible and willing to work some evenings and weekends
Salary will be commensurate with (appropriate) experience
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and anti-racism in your career or that will be made through work at Fred Hutch is requested of all finalists.
Our Commitment to Diversity
We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at email@example.com or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.